RECRUITING

Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening

Conditions

Colorectal Cancer Screening Hepatitis C Virus Screening HCV Screening CRC Screening Colorectal Cancer (CRC)Hepatitis C Virus (HCV)

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This innovative Multilevel Action Toward Colorectal Cancer (CRC) and Hepatitis C Virus (HCV) Education and Screening (MATCHES) intervention aims to promote concurrent HCV and CRC screening among FQHC patients ages 45-75.

Official Title

Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening (MATCHES)

Quick Facts

Study Start:2024-10-21

Study Completion:2028-04-30

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06745895

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:45 Years to 75 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Participants must be receiving care at one of the participating FQHC clinics. * Participants must be 45-75 years of age. * Participants must not be up to date with Colorectal Cancer (CRC) screening recommendations such as no colonoscopy in the past 10 years, occult blood test in the past 12 months. * Participants must never have had Hepatitis C Virus (HCV) antibody screening. * Participants must be able to read, write, and understand English or Spanish. * Participants must have no personal history of CRC or current presumptive CRC symptoms such as unresolved rectal bleeding or abdominal pain/bloating. * Participants must be at average risk for CRC (no hereditary CRC syndromes such as lower gastrointestinal (GI) bleeding, persistent diarrhea, bloating, or lower GI pain, no strong family history of CRC). * Participants must be asymptomatic for HCV. * Participants receiving intervention materials must be able and willing to complete surveys and receive the patient level intervention. * Participants completing qualitative interviews must be willing to complete a remote interview via phone or teleconference software such as ZOOM. * Participants completing qualitative interviews must be willing to be audio recorded. * Participants recruited for qualitative interviews only (did not receive MATCHES intervention materials) must have a clinic visit within prior two months. * All Participants must be able to provide informed consent.	* Participants that do not meet all Inclusion Eligibility requirements will be excluded.

Inclusion Criteria

Exclusion Criteria

* Participants must be receiving care at one of the participating FQHC clinics.
* Participants must be 45-75 years of age.
* Participants must not be up to date with Colorectal Cancer (CRC) screening recommendations such as no colonoscopy in the past 10 years, occult blood test in the past 12 months.
* Participants must never have had Hepatitis C Virus (HCV) antibody screening.
* Participants must be able to read, write, and understand English or Spanish.
* Participants must have no personal history of CRC or current presumptive CRC symptoms such as unresolved rectal bleeding or abdominal pain/bloating.
* Participants must be at average risk for CRC (no hereditary CRC syndromes such as lower gastrointestinal (GI) bleeding, persistent diarrhea, bloating, or lower GI pain, no strong family history of CRC).
* Participants must be asymptomatic for HCV.
* Participants receiving intervention materials must be able and willing to complete surveys and receive the patient level intervention.
* Participants completing qualitative interviews must be willing to complete a remote interview via phone or teleconference software such as ZOOM.
* Participants completing qualitative interviews must be willing to be audio recorded.
* Participants recruited for qualitative interviews only (did not receive MATCHES intervention materials) must have a clinic visit within prior two months.
* All Participants must be able to provide informed consent.

* Participants that do not meet all Inclusion Eligibility requirements will be excluded.

Contacts and Locations

Study Contact

Carol Boxtha

CONTACT

813-745-8963

Carol.Boxtha@Moffitt.org

Shannon Christy, PhD

CONTACT

Principal Investigator

Shannon Christy, PhD

PRINCIPAL_INVESTIGATOR

Moffitt Cancer Center

Clement K. Gwede, PhD, MPH, RN

PRINCIPAL_INVESTIGATOR

Moffitt Cancer Center

Study Locations (Sites)

Moffitt Cancer Center

Tampa, Florida, 33612

United States

Collaborators and Investigators

Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Shannon Christy, PhD, PRINCIPAL_INVESTIGATOR, Moffitt Cancer Center
Clement K. Gwede, PhD, MPH, RN, PRINCIPAL_INVESTIGATOR, Moffitt Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-21

Study Completion Date2028-04-30

Study Record Updates

Study Start Date2024-10-21

Study Completion Date2028-04-30

Terms related to this study

Keywords Provided by Researchers

Screening
HCV Screening
CRC Screening
Colorectal Cancer (CRC)
Hepatitis C Virus (HCV)

Additional Relevant MeSH Terms

Colorectal Cancer Screening
Hepatitis C Virus